Exchange: NASDAQ·Updated 04:45 PM EST

TLX News

News
all
press releases
Telix Pharmaceuticals Limited (TLX) Presents at UBS Global Biopharma Conference 2026 Transcript
Telix Pharmaceuticals Limited (TLX) Presents at UBS Global Biopharma Conference 2026 Transcript...
SeekingAlpha
Telix Pharmaceuticals Limited (TLX) Presents at UBS Global Biopharma Conference 2026 Transcript
Telix Pharmaceuticals Limited (TLX) Presents at UBS Global Biopharma Conference 2026 Transcript...
SeekingAlpha
More News
(RTTNews) - Telix Pharmaceuticals Ltd. (TLX), a commercial-stage company, reported a 19% increase in group revenue and highlighted key operational achievements for the third quarter ended September 30, 2026. The company also reaffirmed its full-year 2026 revenue guidance...
Nasdaq News: Markets
GE HealthCare secures CE Mark certification for MINItrace Magni and expands Copper-64 production capabilities, strengthening its PET imaging and theranostics portfolio.
Zacks
(RTTNews) - Friday, Profound Medical Corp. (PROF) and Telix Pharmaceuticals Limited (TLX) announced a co-education agreement to educate physicians and prostate cancer centers on the complementary roles of Telix's PSMA-PET molecular imaging technologies and Profound's MRI-guided T...
Nasdaq News: Markets
The average of price targets set by Wall Street analysts indicates a potential upside of 83.4% in Telix Pharmaceuticals Limited (TLX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
Telix Pharmaceuticals acquires ITM Isotope for $1.65B to create a radiopharmaceutical leader. Here is what investors need to know.read more...
Benzinga
U.S. futures rose, but Novo Nordisk fell 4.8% after Cagrisema trial results; Aligos, Telix and other stocks also dropped premarket.read more...
Benzinga
(RTTNews) - Telix Pharmaceuticals Ltd. (TLX,TLX.AX) announced that it signed an agreement to acquire privately held ITM Isotope Technologies Munich SE in a transaction valued at up to US$2.35 billion, strengthening its position in the global radiopharmaceutical and radioisotope m...
Nasdaq News: Markets
FDA approves Telix Pharmaceuticals' Pixclara, the first radiopharmaceutical brain cancer imaging drug for glioma PET scans.read more...
Benzinga
The FDA’s target date for deciding on Pixclara is September 11.
Stocktwits

Advertisement|Remove ads.